PAA are managing it precisely like another stock I am in - BOT. BOT have a pipeline of Ph2/3 drugs for acne, rosacea, and anti-microbial, but their sole focus is on one product for axillary hyperhidrosis. That's where they are focusing all of their money and energy. That is the quickest path to either a takeover or become a revenue-producing company.
Exactly the same with PAA. Nothing is 'lost' - but the smart business move is to put all of their time, energy and money toward MPL. That is the quickest path to either a takeover or become a revenue-producing company.
PAA are managing it precisely like another stock I am in - BOT....
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $32.57K | 186.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 141411 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 255906 | 7 |
View Market Depth
| Last trade - 11.48am 15/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |